Pharmaceutical Excipients Market Report 2026

Pharmaceutical Excipients Market Overview

• Pharmaceutical Excipients market size has reached to $10822.05 billion in 2025 • Expected to grow to $14867 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Rise In Biologics Sales Are Anticipated To Fuel The Growth Of The Pharmaceutical Excipients Market • Market Trend: Introduction Of Advanced High-Purity Excipients To Enhance Drug Stability And Delivery • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Pharmaceutical Excipients Market?

Pharmaceutical excipients refer to components of a drug delivery system that are not active pharmaceutical ingredients (API) but have undergone acceptable safety evaluation. Excipients, which are not active themselves, allow the drug ingredient to be administered to the patient in the proper form and support the mode and site of action. The main types of products in pharmaceutical excipients are inorganic chemicals, organic chemicals, and others. The pharmaceutical inorganic chemical industry is concerned with the manufacture, physical or chemical characteristics of substances, assay techniques, and applications of inorganic substances used as pharmaceutical aids, treatments, and diagnostics. The different functionalities include fillers and diluents, suspending and viscosity agents, coating agents, flavoring agent, sweeteners, disintegrants, colorants, lubricants, and glidants, and others and involve various formulations such as oral formulation, topical formulation, and parental formulation.

What Is The Pharmaceutical Excipients Market Growth Forecast?

The pharmaceutical excipients market size is expected to see strong growth in the next few years. It will grow to $14867 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growth in personalized medicine, surge in biopharmaceutical production, demand for natural and clean-label excipients, technological advancements in excipient synthesis, expansion of contract manufacturing organizations (cmos). Major trends in the forecast period include novel excipient formulations, enhanced drug stability solutions, targeted drug delivery systems, natural and plant-based excipients, multi-functional excipients.

Global Pharmaceutical Excipients Market Segmentation

1) By Product: Inorganic Chemicals, Organic Chemicals, Other Products 2) By Functionality: Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities 3) By Type Of Formulation: Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations Subsegments: 1) By Inorganic Chemicals: Salts, Oxides, Silicates 2) By Organic Chemicals: Sugars, Polymers, Oils And Fats 3) By Other Products: Natural Excipients, Coatings, Antioxidants

What Is The Driver Of The Pharmaceutical Excipients Market?

The rise in biologics sales is expected to propel the pharmaceutical sterility testing market going forward. Biologics, or biological products refers to medicines derived from living organisms, including a variety of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Pharmaceutical excipients are used in biologics to enhance stability, improve formulation, and ensure optimal delivery of active biological agents. For instance, in October 2024, according to the Generics and Biosimilars Initiative, a Belgium-based organization, that provides high-quality, scientific information on generic and biosimilar medicines, beyond the nine leading biologics, two additional complex drugs recorded significant sales in 2023. Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes, achieved sales of US$14 billion and US$7.2 billion, respectively. Therefore, the rise in biologics sales is driving the pharmaceutical excipients industry.

Key Players In The Global Pharmaceutical Excipients Market

Major companies operating in the pharmaceutical excipients market are BASF SE, Ashland Global Holdings, Evonik Industries AG, International Flavors & Fragrances Inc, Roquette Frères, Archer Daniels Midland Company, Lubrizol Corporation, Croda International Plc, Kerry Group, DuPont de Nemours Inc., Amster Microcell Private Limited, Finar Limited, P. D. Polychem Private Limited, CAD Pharma Inc, Maas Pharma Chemicals, Aeon Procare Private Limited, CSPC Pharmaceutical Group Ltd, Allen & Hanburys Ltd, Colorcon, MEGGLE GmbH & Co. KG, DMV-Fonterra Excipients GmbH & Co. KG, Alpen Pharma AG, Avantor Inc, JRS PHARMA GmbH & Co. KG, The Dow Chemical Co, EMS Pharma, Biolab Farmaceutica, Medist FZE, W.R. Grace, Univar Solutions, Nitika Pharma, DFE Pharma, Cargill, Sensient Pharma

Global Pharmaceutical Excipients Market Trends and Insights

Major companies operating in the pharmaceutical excipient market are introducing advanced excipients, such as high-purity excipients, to enhance drug formulation stability, improve bioavailability, and support complex drug delivery systems. High-purity excipients refer to pharmaceutical excipients that have undergone advanced purification processes to remove impurities and contaminants. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, launched three new VitiPure excipients designed to enhance the stability and solubility of active pharmaceutical ingredients (APIs). These include VitiPure O 80 Superior, a high-purity polysorbate 80; VitiPure CO 35 Superior, a polyoxyl 35 castor oil; and VitiPure Meglumine LEX, a solubilizer with low bioburden. Targeting various drug delivery applications, especially for sensitive formulations like mRNA vaccines and biologics, these excipients meet the growing demand for high-purity ingredients while adhering to stringent regulatory standards.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Excipients Market?

In March 2024, Roquette, a France-based producer of plant-based ingredients and pharmaceutical excipients, acquired IFF Pharma Solutions for $2.85 billion. This acquisition positions Roquette as a preferred partner in the pharmaceutical industry, aiming to meet evolving customer needs and improve patient outcomes through enhanced treatment options. IFF Pharma Solutions is a US-based company specializes in the production of pharmaceutical excipients and specialty solutions for the pharmaceutical sector.

Regional Insights

North America is the largest region in the pharmaceutical excipients market in 2025. Middle East is expected to be the fastest growing region in the global pharmaceutical excipients market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Excipients Market?

The pharmaceutical excipients market consists of sales of microcrystalline cellulose, stearic acid, gelatin, and tartaric acid. Values in this market are ""factory gate values,"" that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Excipients Market Report 2026?

The pharmaceutical excipients market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical excipients industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.